Fox Chase Cancer Center News

PHILADELPHIA (September 9, 2019) – Andrew J. Andrews, PhD, has been awarded a $33,348 grant from the National Cancer Institute for research attempting to determine the fundamental processes by which cancer cells can sense deficiencies in the production of essential metabolic components and adapt to overcome this and survive.

PHILADELPHIA (September 4, 2019) – Eric D. Tetzlaff, MHS, PA-C, a physician assistant at Fox Chase Cancer Center, has received a $15,000 three-year grant from The Association of Physician Assistants in Oncology to explore the role and impact of burnout among physician assistants working in oncology.

PHILADELPHIA (September 4, 2019) – Research by Carolyn Y. Fang, PhD, and colleagues at Fox Chase Cancer Center showed that among Chinese immigrant women in and around Philadelphia, the relationship between markers of inflammation and risk for breast cancer varied according to their neighborhoods.

PHILADELPHIA (September 3, 2019) — Fox Chase Cancer Center will hold its 20th annual Paws for the Cause, hosted by the Board of Associates, on Sunday, October 6, 2019, from 9:00 am to 12 pm.

PHILADELPHIA (September 3, 2019) – September is National Prostate Cancer Awareness month. The American Cancer Society (ACS) reports that prostate cancer is the most common cancer in American men, other skin cancer.

PHILADELPHIA — (August 28, 2019) Dietmar J. Kappes, PhD, has received a five-year, $626,072 grant from The National Institutes of Health to investigate the role of the immune gene ThPOK in breast cancer.

PHILADELPHIA (August 28, 2019)–Jaye Gardiner, PhD, a postdoctoral researcher in the Edna Cukierman laboratory at Fox Chase Cancer Center,  received a $163,500 grant from the American Cancer Society to support her research into the role of the tumor stroma in pancreatic cancer.

PHILADELPHIA (August 27, 2019) – New insights from researchers at Fox Chase Cancer Center into the structure of full-length human phenylalanine hydroxylase (PAH) may aid ongoing efforts to develop effective treatments for the metabolism disorder phenylketonuria (PKU).